- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 239/24 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
Patent holdings for IPC class C07D 239/24
Total number of patents in this class: 149
10-year publication summary
|
5
|
15
|
10
|
11
|
14
|
4
|
6
|
11
|
9
|
4
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| LG Chem, Ltd. | 17926 |
7 |
| Arvinas Operations, Inc. | 262 |
7 |
| Samsung Display Co., Ltd. | 38544 |
4 |
| Beyondbio Inc. | 10 |
4 |
| Boehringer Ingelheim International GmbH | 4502 |
3 |
| Calitor Sciences, LLC | 37 |
3 |
| Dana-Farber Cancer Institute, Inc. | 2657 |
3 |
| Hutchison MediPharma Limited | 106 |
3 |
| Medshine Discovery Inc. | 587 |
3 |
| Sunshine Lake Pharma Co., Ltd. | 626 |
3 |
| Merck Sharp & Dohme LLC | 3734 |
3 |
| Merck Sharp & Dohme Corp. | 2183 |
2 |
| AstraZeneca AB | 2815 |
2 |
| Semiconductor Energy Laboratory Co., Ltd. | 11780 |
2 |
| University of Florida Research Foundation, Inc. | 4177 |
2 |
| 10X Genomics, Inc. | 1379 |
2 |
| Advenchen Pharmaceuticals, LLC | 23 |
2 |
| Curtana Pharmaceuticals, Inc. | 12 |
2 |
| Gracel Display Inc. | 18 |
2 |
| Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China | 174 |
2 |
| Other owners | 88 |